Takahiro Sano Selected Research

Immunoglobulins (Immunoglobulin)

8/2016

Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takahiro Sano Research Topics

Disease

3	Neoplasms (Cancer) 07/2023 - 06/2017
3	Primary Myelofibrosis (Myelosclerosis) 11/2017 - 01/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2023 - 02/2020
2	Myocardial Infarction 02/2020 - 07/2011
2	Fibrosis (Cirrhosis) 11/2017 - 01/2017
1	Chronic Renal Insufficiency 07/2023
1	Unstable Angina 12/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2022
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2022
1	Inflammation (Inflammations) 01/2022
1	Hemorrhage 05/2021
1	Proteinuria 12/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2018
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Evans Syndrome 11/2017
1	Pancytopenia 11/2017
1	Autoimmune Hepatitis 11/2017
1	Splenomegaly 06/2017
1	Anemia 06/2017
1	Polycythemia (Erythrocytosis) 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Polycythemia Vera 01/2017
1	Lymphadenopathy 08/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2016
1	Immunoglobulin G4-Related Disease 08/2016
1	Dehydration (Water Stress) 07/2014
1	Neoplasm Metastasis (Metastasis) 05/2002
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2002

Drug/Important Bio-Agent (IBA)

2	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 05/2002
2	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 05/2002
2	Rituximab (Mabthera)FDA Link 11/2017 - 08/2016
2	Messenger RNA (mRNA)IBA 06/2017 - 07/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2023
1	asciminibIBA 07/2023
1	fibrin fragment D (D-dimer)IBA 12/2022
1	ravulizumabIBA 12/2022
1	Troponin IIBA 12/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2021
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2021
1	nilotinib FDA Link 02/2020
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 12/2018
1	Lenalidomide (CC 5013)FDA Link 12/2018
1	Ifosfamide FDA LinkGeneric 01/2018
1	Reticulin (Reticular Fiber)IBA 11/2017
1	SteroidsIBA 11/2017
1	Janus Kinase InhibitorsIBA 01/2017
1	ruxolitinibIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 08/2016
1	Therapeutic UsesIBA 08/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2016
1	Prednisolone (Predate)FDA LinkGeneric 08/2016
1	Immunoglobulins (Immunoglobulin)IBA 08/2016
1	Indicators and Reagents (Reagents)IBA 07/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2002
1	Cisplatin (Platino)FDA LinkGeneric 05/2002
1	Tumor Biomarkers (Tumor Markers)IBA 05/2002
1	pro-gastrin-releasing peptide (31-98)IBA 05/2002
1	Topotecan (Hycamtin)FDA LinkGeneric 05/2002
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2002
1	taxaneIBA 01/2002

Therapy/Procedure

3	Therapeutics 12/2018 - 08/2016
2	Drug Therapy (Chemotherapy) 05/2021 - 01/2002
2	Radiotherapy 01/2018 - 05/2002
1	Kidney Transplantation 07/2023
1	Remission Induction 05/2021
1	Tracheotomy 01/2018
1	Aftercare (After-Treatment) 11/2017